Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions

Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and ProlixinRX (Fluphenazine) Provides Off-Label Drug Candidates - Jilan Nazeam, Esraa Z. Mohammed, Mariam Raafat, Mariam

Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review - Abidemi J. Akindele, Abimbola Sowemimo, Foluso O. Agunbiade, Margaret O. Sofidiya, Olufunsho Awodele, Omobolanle Ade-Ademilua, Ifeoma Orabueze, Ismail O. Ishola

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus - ScienceDirect

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment

Small molecules in the treatment of COVID-19

Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats [

IJMS, Free Full-Text

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Frontiers Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro